Orphazyme’s arimoclomol receives US Fast Track Designation in Amyotrophic Lateral Sclerosis
22 mai 2020 01h52 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Capital increase of 1,927 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units
23 avr. 2020 09h13 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
22 avr. 2020 06h07 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Capital increase of 4,616 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units
20 avr. 2020 08h23 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
17 avr. 2020 06h15 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Resolutions passed at the Annual General Meeting
26 mars 2020 12h51 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Orphazyme publishes listing prospectus in connection with listing of shares
16 mars 2020 03h32 HE
|
ORPHAZYME A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF...
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
11 mars 2020 17h25 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No. 26/2020 ...
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
10 mars 2020 09h44 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
04 mars 2020 08h07 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No. 24/2020 ...